Dr.Zone AI

The Lancet | General Medicine | Dr.Zone AI

The Lancet (General Medicine): [Comment] Can oral GLP-1 receptor agonists ACHIEVE the same as SGLT2 inhibitors? Pharmacotherapy for the treatment of type 2 diabetes has changed profoundly. SGLT2 inhibitors and GLP-1 receptor...